Search Results

Explore this week’s research, tools, and biotech insights in one place. The insights are ready.

Kenakin revealed  practical ways to anticipate these system-level interactions before they appear as Allosteric modulators interact with the system already in motion, shaping the receptor’s behavior without Enzyme Behavior: The Nonlinear Gatekeeper In GPCR programs, CYP interactions often appear late—usually It equips pharmacologists, discovery teams, and biotech leaders to see around mechanistic corners, recognize

The Boston biotech revealed Wednesday afternoon that it would downsize its research to focus on its lead

insights from major conferences, emerging research, and expert commentary Whether you’re a pharmacologist, biotech GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who

Receptor Design and Synthesis of Novel GPR139 Agonists with Therapeutic Effects in Mouse Models of Social Interaction Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies-An Interim Chris Cargill Wins Executive of the Year at the Citeline Pharma Intelligence Awards Japan 2023 Salipro Biotech Conference November 20 - 23, 2023 | ASCEPT Annual Scientific Meeting February 3 - 7, 2024 | SLAS2024 International

pathway of opioid drugs into cellular structures Inversago Pharma will present at BBHIC 2023 Orion Biotechnology attended the Swiss Biotech Day Addex Therapeutics attended the Swiss Biotech Day Sosei Heptares presented

Pairaudeau, CTO of Exscientia discuss transforming drug discovery using their AI-driven platform Salipro Biotech I-GPCRNet (October 25 - 27, 2023) GPCR Retreat (November 2 - 4, 2023) Structure, Mechanism, and Drug Interactions

January 2022 "G-protein-coupled receptors’ star has been on the rise in biotech in recent years as researchers

fruitful research space has led to more than 700 approved drugs over previous decades—but the two-year-old biotech

Plus: must-read chemokine and PTH1R papers, and new momentum across biotech—from Superluminal to Neurocrine

Since then, Celniker has helped usher in an additional fund and headed a few startups as interim CEO. That money has gone to some 60 biotechs, much of it as early funding."

(“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, announced

Our partner, Domain Therapeutics, will attend the SACHS 23rd annual biotech event in Europe. Dr. Therapeutics CEO Pascal Neuville to Discuss Game-Changing GPCR-Targeting Immunotherapies at Sachs Associates' Biotech Conference November 20 - 23, 2023 | ASCEPT Annual Scientific Meeting February 3 - 7, 2024 | SLAS2024 International

spots in your drug evaluation process, moving beyond simple potency measures to understand the dynamic interactions GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

Industry News Biotech startup Structure pulls off rare IPO, raising $161M 3-drug combo leads to 'unprecedented Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) arcoscreen is one of the 13 biotech SLAS2023 International Conference and Exhibition (February 25 - March 1, 2023). 2nd ERNEST Training School

I've seen this pattern unfold across biotech, academia, and nonprofits. The assays are running, data is flowing in from your CROs or your internal labs , yet progress stalls Internal data and CRO outputs  misaligned with strategic goals.

For drug hunters working at the GPCR interface, the difference between a successful lead and a dead-end Kenakin Content trusted by biotech, pharma & academia 💎 $2999/year — one conference cost = a full If you’re still treating orthosteric and allosteric interactions as interchangeable, you’re leaving precision

Updates in GPCR Research GproteinDb in 2024: new G protein-GPCR couplings, AlphaFold2-multimer models and interface interactions Experimental modulation of physiological force application on leg joint neurons in intact Showcases Innovative AI-Driven Drug Design at BRIC AI 2023 Workshop Salipro Biotech AB Celebrates Milestones Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk February 3 - 7, 2024 | SLAS2024 International

GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

unanswered questions about blockbuster weight-loss drugs Transforming Drug Discovery: Insights from Viva Biotech's Meeting 2025 May 12 - 15, 2025 | PEGS 2025 May 20 - 22, 2025 | SLAS Europe 2025 June 16 - 19, 2025 | BIO International

epithelial proliferation, migration, and cellular respiration Spatiotemporal Optical Control of Gαq-PLCβ Interactions Biotherapeutics in Idiopathic Pulmonary Fibrosis Former execs from Pfizer obesity drug program have started a new biotech Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk February 3 - 7, 2024 | SLAS2024 International

incretin biology depends on more than ligand potency — it hinges on where receptors actually are, how they internalize how his team uses fluorescence tools and chemically engineered ligands to map receptor distribution, internalization datasets, balancing innovation with assay rigor, or working across chemistry–pharmacology–physiology interfaces GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

the Classified GPCR News from March 25th to March 31st, 2024 GPCR Activation and Signaling PACAP key interactions Secures VLAIO Grant Supporting Drug Discovery & Development In Endocrine And Metabolic Diseases How biotech Clinical Pharmacology 2026 GPCR Jobs Postdoctoral Associate Research Technologist I Senior Scientist- Internal

curriculum with your topic suggestions Weekly new releases  to stay ahead of the science Content built for biotech

Surveying nonvisual arrestins reveals allosteric interactions between functional sites. of Alcohol and Substance Use Disorders AbbVie recruits a GPCR team in Oxford, buying out a fledgling biotech

To solve this industry-wide problem, Orion Biotechnology (Orion) is introducing a novel solution driven technological advances related to the understanding of structure and activation mechanisms of GPCRs, the biotech investment community has injected significant funding into small biotech companies developing novel About Orion Biotechnology Orion’s mission is to unlock the therapeutic potential of previously undruggable For more information, follow Orion Biotechnology on LinkedIn or visit www.orionbiotechnology.com.

26RFa by the pyroglutamylated RFamide peptide receptor Industry News NanoImaging Services and Cube Biotech

GPCR scientists, translational pharmacologists, biotech discovery teams, platform company leaders, and

Mid-2025 How GPCR agonists, including antibodies, are shaping the future of metabolic care Salipro Biotech Meeting 2025 May 12 - 15, 2025 | PEGS 2025 May 20 - 22, 2025 | SLAS Europe 2025 June 16 - 19, 2025 | BIO International assemble the ternary parathyroid hormone-GPCR-arrestin complex Myosin VI drives arrestin-independent internalization

Industry News Orion Biotechnology at the AACR 2023. (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) NEW ASPET 2023 - American Society for Pharmacology